Teva gets approval for generic version of pain reliever Celebrex

June 11, 2014

The U.S. Food and Drug Administration (FDA) has approved the first generic versions of pain relieving drug product Celebrex (celecoxib).

The U.S. Food and Drug Administration (FDA) has approved the first generic versions of pain relieving drug product Celebrex (celecoxib). The medicine is used for treatment of rheumatoid arthritis, osteoarthritis and short-term pain, among other conditions.

The approval issued to Israeli company Teva Pharmaceutical Industries allows the company to manufacture and distribute celecoxib capsules in 50 mg, 100 mg, 200 mg and 400 mg strengths. All types of celecoxib, except for the 50 mg strength, have a 180-day exclusivity period. The regulator also approved marketing of 50 mg celecoxib capsules by Mylan Pharmaceuticals, Inc.

Commenting on the approval, Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said that it was essential for U.S. consumers to have access to affordable and reliable options for treatment of various chronic conditions. Americans should be aware that approved products have passed rigorous evaluation before receiving approval, she added.

Celecoxib is classed as a non-steroidal anti-inflammatory drug. This means that, like all other products in this group, it will have a boxed warning to alert patients and healthcare professionals that there is a risk of heart attack or death, especially in patients with one or more risk factors present. Other side effects registered in clinical trials include abdominal pain, indigestion and diarrhea, swelling of the feet or legs, dizziness, runny nose and rash, the FDA said.

Sponsored Recommendations

Choosing The Right Partner for CHIPS Act Investments

As the U.S. looks to invest in the semiconductor research and production using CHIPS Act 2022 funding, it's important to choose the right partner.

EMWD Uses Technology to Meet Sustainability Goals

Eastern Municipal Water District pilots artificial intelligence-enabled control and machine learning to help save energy, reduce costs, and improve quality.

Protein Processing Solutions: Automation & Control

For protein processors looking to address industry challenges, improve efficiency, and stay ahead in a competitive market, Rockwell Automation offers tailored automation, control...

Automotive Manufacturing Innovation: Smart Solutions for a Connected Future

Rockwell Automation provides automation and control systems tailored for the automotive and tire industries, supporting electric vehicle production, tire production, battery production...